G protein-coupled receptors (GPCRs) coupling to G i/o signaling pathways are involved in the control of important physiological functions, which are difficult to investigate because of the limitation of tools to control the signaling pathway with precise kinetics and specificity. We established two vertebrate cone opsins, short-and long-wavelength opsin, for longlasting and repetitive activation of G i/o signaling pathways in vitro and in vivo. We demonstrate for both opsins the repetitive fast, membrane-delimited, ultra light-sensitive, and wavelength-dependent activation of the G i/o pathway in HEK cells. We also show repetitive control of G i/o pathway activation in 5-HT 1A receptor domains in the dorsal raphe nucleus (DRN) in brain slices and in vivo, which is sufficient to modulate anxiety behavior in mice. Thus, vertebrate cone opsins represent a class of tools for understanding the role of G i/o -coupled GPCRs in health and disease.
INTRODUCTION
G protein-coupled receptors (GPCRs) represent the major protein family for the conversion of extracellular cues into intracellular signals. GPCRs couple mainly to three signaling pathways, i.e., G i/o , G q , and G s . Among them, the G i/o pathway is involved in various signaling processes including the fast dampening of neuronal activity via activation and inhibition of ion channels (e.g., K + or Ca 2+ currents) and the slow modulation of enzymatic cascades (e.g., adenylyl cyclase and extracellular signal regulated kinase [ERK] ). Important transmitters systems and GPCRs activating the G i/o pathway are, for example, GABA (GABA Breceptors), endocannabinoids (CB1-receptors), and serotonin (5-HT 1 -receptors) representing important drug targets for different brain diseases. Unfortunately, current drugs and molecular tools available to investigate and manipulate these GPCRs in health and disease have various limitations for example in GPCR and/or pathway specificity, in the precise control of the activation and deactivation kinetics of the GPCR pathway, and in the subcellular-specific control of the GPCR pathway in a defined neuronal circuit. In order to overcome these problems, we developed optogenetic tools, the vertebrate cone opsins, for fast, repetitive, and ultra light-sensitive control of G i/o pathways in specific receptor domains, such as the 5-HT 1 receptors, in vivo without supply of any external ligands. 5-HT 1 receptors act as so-called autoreceptors in serotonergic neurons and as heteroreceptors in non-5-HT neurons to modulate serotonergic tone (McDevitt and Neumaier, 2011; Sharp et al., 2007) . Among them, the 5-HT 1A receptor is the most prominent receptor localized on somatodendritic areas of 5-HT and nonserotonergic neurons within the DRN and has been implicated in a variety of psychiatric disorders including anxiety and depression (Sharp et al., 2007) . To understand the precise function of 5-HT 1A receptors and in general other G i/o -coupled GPCRs, it will be important to repetitively and precisely control 5-HT 1A receptor signaling cascades in cells and subcellular compartments where 5-HT 1A receptors are located (i.e., 5-HT 1A receptor domains) or GPCR-specific domains over long time periods in vivo.
In recent years, various approaches have been developed to control GPCR signaling. These approaches include chemical and optogenetic approaches such as DREADDs, RASSLS, engineered GPCRs for binding of light-activated ligands, and vertebrate and invertebrate rhodopsin/opsins (Armbruster et al., 2007; Herlitze and Landmesser, 2007; Masseck et al., 2011) . DREADDs and RASSLS use chemically inert ligands where the activation of the signaling pathways is difficult to control temporally. Engineered GPCRs tethered to light-activatable ligands, such as the recently developed LimGluR2 (Levitz et al., 2013) are limited by the fact that a photoactivatable ligand has to be applied, which will be difficult to supply in particular in the mammalian brain. Vertebrate rhodopsin has the disadvantage that sustained and repetitive GPCR activation leads to a decline in signaling response (Levitz et al., 2013) .
In order to overcome this problem and to further develop the use of G i/o -coupled light-activated GPCRs in neurons we used two opsins from the vertebrate eye involved in color vision, i.e., the short-and long-wavelength opsin (vSWO and vLWO), which have been used in cultured cells to control slow G i/o signals (Karunarathne et al., 2013) . We found that fast, membrane-delimited intracellular G i/o signals activated by the vertebrate opsins in comparison to rhodopsin do not decline in amplitude during repetitive stimulation and can be sustained for minutes. The light sensitivity for vertebrate rhodopsins/opsins is much higher in comparison to other optogenetic tools such as the ultra lightsensitive ChR2 variant CatCh and the halorhodopsin variant eNpHR 3.0 were maximally activated at 2 mW/mm 2 (Kleinlogel et al., 2011; Gradinaru et al., 2010) contributing to a superb in vivo performance. Indeed, vertebrate cone opsins can be used for repetitive G i/o activation in vivo without application of any further ligands and are suitable to control emotional behavior in mice. Therefore, vSWO and vLWO are tools for the control of neuronal G i/o signaling pathways in vivo and represent the tools of choice to understand and dissect the function of G i/o signals in health and disease.
RESULTS

Repetitive Activation of vLWO and vSWO in a Heterologous Expression System
Recently, we established vRh as a tool to control the G i/o signaling pathway in vitro and in vivo (Gutierrez et al., 2011; Li et al., 2005; Oh et al., 2010) . vRh has the limitation that light-induced signaling responses decline during repetitive stimulation ( Figures 1A and 1B ) (Levitz et al., 2013) . In order to overcome this problem, we tested different vertebrate opsins from the human and mouse eye involved in color vision, i.e., vSWO (mouse) and vLWO (human) opsins for their capabilities to modulate GIRK channel activity repetitively and over long time periods. GIRK channels are modulated in a membrane-delimited, fast manner via the G i/o pathway (Hille, 1994; Mark and Herlitze, 2000) . We compared the amplitudes and kinetics of lightinduced activation and deactivation of GIRK channels between vSWO, vLWO, and vRh when expressed in HEK293 cells stably expressing GIRK1/2 subunits (kindly provided by Dr. A. Tinker, UCL). We found that vSWO, vLWO, and vRh induced large GIRK current amplitudes during a 1 s, 2 mW/mm 2 light pulse (i.e., 450 nm, 590 nm, and 475 nm, respectively) ( Figures 1A  and 1E ). Repetitive 1 s long light stimulation of GIRK currents did not decline in amplitude for light activation of vSWO and vLWO during 20 trials (20 min, Figures 1A and 1B) . In comparison, GIRK current amplitude declined to 20% of the original amplitude elicited by the first light pulse when vRh was coexpressed ( Figures 1A and 1B) . In addition, GIRK channel activation and deactivation kinetics were faster when GIRK channels were activated by the cone opsins in comparison to vRh ( Figures  1C and 1D ). As previously shown for vRh, vSWO and vLWO do not activate GIRK currents in the absence of light suggesting that leak activity in the dark is minimal ( Figure S1 available online) (Oh et al., 2010) . In addition, fusion of the C terminus (CT) of the 5-HT 1A receptor to the CT of the mCherry or eGFP-tagged vSWO or vLWO does not change the light activation properties of the vertebrate opsins ( Figures 1B-1E ). Figures S2 and S3 ). In comparison, the ultra 
Neuron
Control of G i/o Signaling by Cone Opsins light-sensitive ChR2 variant CatCh and the halorhodopsin variant eNpHR 3.0 were maximally activated at 2 mW/mm 2 ( Figure S4 ) (Kleinlogel et al., 2011; Gradinaru et al., 2010) . This suggests that light activation of vSWO and vLWO is very sensitive in comparison to other ChR and halorhodopsin variants. Therefore, vSWO and vLWO should be suitable for light activation of G i/o signaling cascades in deep brain areas in vivo.
Subsequently, we investigated the light-time dependence of GIRK channel activation at 0.02 mW/mm 2 light-intensity (Figure 2B) . We found that for all three light-activated GPCRs 1 s light pulses are necessary and sufficient to activate the maximal GIRK current. To activate around 50% of maximal GIRK current 50 ms light pulses were sufficient for vRh, 200 ms for vLWO, and 500 ms for vSWO. GIRK current activation became faster with increasing light duration, while GIRK current deactivation was independent of the light pulse duration ( Figure 2C ). During 60 s long light stimuli, GIRK current declined to a steady state to 70% (vLWO), 78% (vSWO), and 73% (vRh) of the maximal light-activated GIRK current ( Figures  2D and 2E ), which is faster for vLWO in comparison to vSWO and vRh ( Figure 2F ).
Spectral Tuning of vOpsins
The mouse blue SWS1 opsin (OPN1SW) has an absorption maximum of 360 nm while the human M/LWS opsin (OPN1LW) has its absorption maximum between 550-560 nm (Ebrey and Koutalos, 2001) . We reasoned that an important potential use of vSWO and vLWO would be combinatorial stimulation of G i/o responses in different subcellular domains. Thus, we investigated whether or not we could activate the two opsins independently and separately with two different wavelengths of light, i.e., blue and red light and tested the spectral sensitivity of vSWO and vLWO in a heterologous expression system at different light intensities ( Figure 3 ). When using 1% light (i.e., 0.02 mW/mm 2 )
vSWO induced the maximal GIRK current response at 380 nm, which is the shortest wavelength we could apply with our light source. At wavelength longer than 510 nm light-induced GIRK currents are <10% of maximal-induced current. In comparison, vLWO maximally induced GIRK currents by wavelengths larger than 450 nm and shows <20% of the light-induced GIRK current at 380 nm ( Figure 3A ). The wavelength-dependent activation of GIRK currents is also dependent on the light intensities, in particular for vLWO, being more specific at low (0.002 mW/mm 2 ) and high (2 mW/mm 2 ) light intensities ( Figure 3B ). Thus, it is possible to activate GIRK currents by two different wavelengths of light at different light intensities using vSWO and vLWO. vSWO has a higher wavelength specificity than vLWO.
Wavelength-Specific Control of Hyperpolarization in DRN Neurons of Brain Stem Slices
In order to achieve sufficient light activation of the G i/o pathway in a specific receptor domain in neurons we tagged both opsins with the CT of the 5-HT 1A receptor (vLWO 5-HT1A and vSWO 5-HT1A ). Recently, we showed that tagging vRh with the 5-HT 1A receptor CT targets and functionally substitutes for 5-HT 1A receptors (Oh et al., 2010) . To investigate if vertebrate opsins are superb optogenetic tools to investigate intracellular signaling pathways in neurons, we expressed vLWO 5-HT1A and vSWO 5-HT1A in neurons of the dorsal raphe (Figures 4 and 5). We created AAV2 viruses for expression of the two opsins in mouse brain and injected the virus into the DRN of mice, a nuclei with high concentration of serotonergic and GABAergic neurons. 5-HT 1A receptors in the DRN modulate neuronal firing via activation of GIRK current induced membrane hyperpolarization (Maejima et al., 2013) . We therefore investigated if vSWO 5-HT1A and vLWO 5-HT1A induce hyperpolarization of DRN neurons when activated by light and if light-induced hyperpolarization is wavelength-specific. Indeed, vSWO 5-HT1A -and vLWO 5-HT1A -expressing neurons hyperpolarize within a second by $10 mV when a 2 s light pulse (1 mW/mm 2 ) of 400 nm or 590 nm is applied, respectively ( Figures 4A and 4B ). The amount of lightinduced hyperpolarization is comparable to the hyperpolarization induced by 5-HT ( Figures 4A and 4B ). In addition, the light-induced hyperpolarization is opsin-and wavelength-specific, because vSWO 5-HT1A expressing neurons do not respond to red light, and vLWO 5-HT1A expressing neurons do not respond to blue light. The light-induced hyperpolarization can be elicited various times during the slice recordings ( Figure S5 ). Lightinduced hyperpolarization occurs within a second, and repolarization to resting membrane potential after light is switched off 2 ) were applied, and normalized GIRK currents were calculated for each individual cell (mean ± SEM; n = 5).
(B) Relative GIRK currents induced by vSWO and vLWO at different lightintensities at 400 nm and 600 nm light. One second 400 nm and 600 nm light pulses of the indicated light-intensities were applied and GIRK currents were normalized to the largest current elicited with 0.02 mW/mm 2 light (mean ± SEM; n = 5).
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Control of G i/o Signaling by Cone Opsins takes $20 s ( Figure 4C ). We next investigated if light-induced hyperpolarization is mediated via light activation of a rectifying current. We concentrated here on vSWO 5-HT1A , which we used later for the behavioral experiments (see below). Light activation of vSWO 5-HT1A expressed in DRN neurons induced an inward rectifying current (most likely GIRK current) of $75 pA at À110 mV ( Figures 4D and 4E ), which is comparable to the current activated by application of 100 mM 5-HT. Most importantly, the inward current at À110 mV before light, the resting membrane potential, the input resistance, and the capacitance is comparable between vSWO 5-HT1A expressing and noninfected control DRN neuron ( Figure 4F ; Table S1 ) suggesting that vSWO 5-HT1A has a low dark activity and does not change the physiological properties of the neurons. Various GPCRs such as the 5-HT 1A or GABA B coupling to the G i/o pathway are involved in the autoregulation and heteroregulation of 5-HT release in the DRN (Maejima et al., 2013) . We examined if light activation of vSWO 5-HT1A in 5-HT 1A receptor domains would be sufficient to control anxiety-related behavior, i.e., open-field, elevated plus-maze, and novelty-suppressed feeding. When See also Figure S6 .
Control of G i/o Signaling by Cone Opsins
tested in the open-field, light activation of vSWO 5-HT1A within the dorsal raphe nucleus (DRN) increased the time spent in the center of the arena significantly (p < 0.01) in comparison to control mice ( Figures 6A-6C ). The increase in center time during activation of the vSWO 5-HT1A is not due to changes in motor performance, because the overall distance traveled is not significantly different ( Figure 6D ). In the novelty-suppressed feeding, light activation of vSWO 5-HT1A reduced the latency to feed with no change in food consumption ( Figures 6E and 6F ). In contrast, no difference in behavior in the elevated plus-maze experiments during light stimulation of vSWO 5-HT1A could be detected (data not shown).
The results suggest that activation of the G i/o pathway in cellular compartments where 5-HT 1A receptors are located in the DRN regulate certain aspects of anxiety behavior. Thus, vertebrate opsins are outstanding optogenetic tools for controlling neuronal G i/o signaling and to modulate G i/o signaling in G i/o -coupled receptor domains to investigate emotional behavior in mice.
DISCUSSION Vertebrate Opsins Are Tools for Precise Control of G i/o Signals in Mouse Brain
In recent years, various methods have been developed to control GPCR pathways. These include optogenetic approaches using vertebrate and invertebrate rhodopsin/opsins, chemical approaches such as DREADDs and RASSLs, and most recently, chemico-optogenetic approaches such as LimGluR (Levitz et al., 2013; Masseck et al., 2011) . DREADDs, RASSLs, and LimGluR have the advantage that most likely coupling and activation of G protein signals is receptor-type-specific. However, a detailed analysis of which pathways are actually activated in subcellular areas of neurons and if these are receptor specific has not been demonstrated. DREADDs, RASSLs, and LimGluRs are activated by synthetic ligands, which have to be applied to living animals either by injection or feeding. In the case of DREADDs and RASSLs, the GPCR activation and deactivation is therefore difficult to control on a fast timescale. LimGluRs, which are activated by a light-activatable, tethered synthetic ligand can be controlled precisely and reliably by light (Levitz et al., 2013) . LimGluRs will have a great potential for deciphering receptor function, when knockin animals are produced to introduce the tethering site into the native GPCR. LimGluRs still have the disadvantage that synthetic ligands are needed to obtain functional light-driven receptors. In comparison to the chemical and chemico-optogenetic approaches, vertebrate rhodopsins/opsins have the advantage that no ligand has to be applied when expressed for example in the mammalian brain. The light-activated GPCRs seem to be 
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Control of G i/o Signaling by Cone Opsins reloaded with 11-cis retinal during repetitive stimulation, an effect that has been observed early in HEK293 cells (Brueggemann and Sullivan, 2002) . Up to this point, the disadvantage of rhodopsin has been the decline in G protein signal amplitude (tested for GIRK channel activation) and its slow deactivation kinetics (Levitz et al., 2013) . However, by using vertebrate opsins, we could repetitively activate K + conductances in HEK293 cells and modulate neuronal activity in brain slices and in vivo without a decline in response amplitude with fast activation and deactivation kinetics, which are similar to signal activation by endogenous GPCRs and with much lower light intensities than the ultrasensitive channelrhodopsin variant CatCh and the halorhodopsin variant eNpHR3.0 (Gradinaru et al., 2010; Kleinlogel et al., 2011) . It has been estimated that the G protein activation, as well as the deactivation of the signaling cascade, is much faster in cones than in rods. The fast deactivation is most likely related to the fact that phosphorylation of the activated GPCRs is 50 times higher in cones than that in rods (Kawamura and Tachibanaki, 2008) . These mechanisms most likely contribute to the fast recovery from light responses in cones and may also contribute to the differences in signal termination by arrestins and G protein-coupled receptor kinases (GRKs) between vRh and vOpsins in other cell types. Fortunately, arrestin and GRK isoforms are expressed ubiquitously. For example, HEK293 cells express mRNAs of arrestin b1,2 and GRK3,4 (Atwood et al., 2011) ( Figure S3 ) and embryonic dorsal raphe neurons express mRNA of arrestin b1,2 and GRK5/6 (Wylie et al., 2010) . In addition, both cell types express rhodopsin like class A GPCRs. Therefore, it is very likely that signal termination of vRh and vOpsins in HEK293 cells and neurons involves the recruitment of endogenous arrestin and GRK isoform. Arrestins are also important for regeneration of the aporeceptor with 11 cis-retinal (Sommer et al., 2012) . In addition, the half-time of release of retinal from vSWO is 250-fold faster than that of rhodopsin (Chen et al., 2012) . Thus, the faster deactivation of the light response as well as the faster release of retinal in cone opsins most likely contribute to the faster deactivation kinetics and the stable response amplitude of the cone opsins in comparison to the rod rhodopsins when expressed in HEK cells or neurons. One important difference between the different cone and rod pigments is that they are maximally activated at different wavelength of light. The mouse and human vSWO and vLWO opsins, which we used in our study, have excitation peaks at 360 nm and 550-560 nm, respectively (Ebrey and Koutalos, 2001) . In order to investigate the possibility to activate different G protein signals at different wavelengths of light, we first tested the wavelengthdependence of GIRK channel activation in HEK cells when either vSWO or vLWO are coexpressed. We found that vSWO maximally activates GIRK current at 380-400 nm while vLWO activated GIRK currents between 550-650 nm. Both receptors activate GIRK currents to <45% (vLWO) or 18% (vSWO) of its maximal amplitude at wavelength shorter (vLWO) or longer (vSWO) than the maximal excitation peaks. This activation of GIRK currents at shorter wavelength for vLWO most likely reflects the relative absorbance of the visual pigments at lower wavelength (Nikonov et al., 2006) . The wavelength specificities of the opsins are light intensity-dependent becoming more specific at lower (0.002 mW/mm 2 ) and higher (2 mW/mm 2 ) light intensities. In fact, in the brain slice recordings, light-induced hyperpolarization was wavelength-specific (1 mW/mm 2 ). Hyperpolarization could only be induced by blue but not red light in vSWO 5-HT1A expressing neurons and by red but not blue light in vLWO 5-HT1A expressing neurons. Most importantly, dark activity of at least vSWO 5-HT1A is very low, because no differences in the inward current at À110 mV was detected between vSWO 5-HT1A -expressing and control neurons in the absence of light. Thus, the combinatorial use of vLWO and vSWO gives the opportunity to control different G i/o receptor responses in subcellular receptor domains in vitro and in vivo, in particular when light-dependent GPCRs are targeted to different subcellular structures.
Activation of G i/o Signals in 5-HT 1A Receptor Domains by Vertebrate Opsins in the Dorsal Raphe Nuclei Reduces 5-HT Firing and Relieves Anxiety in Mice A change in 5-HT levels in the brain has been associated with various behavioral changes including anxiety and suppression of 5-HT 1A autoreceptors and/or constitutive knockout of 5-HT 1A increase anxiety behaviors in mice (Gross et al., 2000; Heisler et al., 1998; McDevitt and Neumaier, 2011; Parks et al., 1998; Ramboz et al., 1998; Richardson-Jones et al., 2011) . We therefore tested if anxiety behavior can be modulated by activation of G i/o signals in the DRN in 5-HT 1A receptor domains as would be expected from the anxiolytic effects of infusion of 5-HT 1A receptor agonists in the DRN (Graeff et al., 1998; Higgins et al., 1988 Higgins et al., , 1992 Hogg et al., 1994; Remy et al., 1996; Romaniuk et al., 2001) . Increasing evidence suggest that besides their prominent role as autoreceptors, 5-HT 1A receptors expressed in non-5-HT neurons, such as GABAergic interneurons connected to 5-HT neurons in the DRN, also contribute to the modulation of serotonergic firing (Beck et al., 2004; Gocho et al., 2013; Kirby et al., 2003; Sharp et al., 2007) . Indeed, activation of vSWO tagged with the CT from 5-HT 1A receptors relieves anxiety in mice in the open-field and novelty-suppressed feeding test but not in the elevated plus-maze. Our results are in agreement with behavioral analysis of conditional suppression of 5-HT 1A autoreceptors in serotonergic neurons. The conditional suppression of the 5-HT 1A increases anxiety behavior in the open field and novelty-suppressed feeding, but not in the elevated plus-maze (Richardson-Jones et al., 2010 . The different behavioral assays most likely test different aspects of anxiety such as exploration of aversive environments and stress-induced anxiety and suggest that certain aspects of anxiety behavior are regulated by G i/o signals/5-HT 1A receptors in the DRN. This is a demonstration that a light-controlled G i/o pathway can modulate certain aspects of anxiety behavior. Thus, the targeting of light-gated GPCRs into specific receptor domains, its activation of a specific G protein pathway in combination with cell-type-specific expression such as serotonergic neurons or GABAergic neurons will elucidate signaling mechanisms in the raphe nuclei in relation to emotional behavior in future studies. Because the activation of G i/o pathway in DRN neurons relieves certain aspects of anxiety, this lightgated GPCR approach might be applicable for new therapeutic strategies. 
Control of G i/o Signaling by Cone Opsins
Cell Culture and Infection
Cell culture and maintenance of human embryonic kidney 293 (HEK293) cells were performed as described previously (Wittemann et al., 2000) . Stably expressing GIRK1/2 subunits HEK293 cells (kindly provided by Dr. A. Tinker, UCL London) were transfected with Lipofectamine2000 (Invitrogen) and incubated for 18-24 hr before recordings.
AAV2 Virus Production, Surgery, Virus Injection, and Cannula Placement Recombinant adeno-associated virus stocks serotype 2 were produced either according to the AAV Helper-Free System manual (Stratagene) or by the plasmid cotransfection method (Choi et al., 2007) and purified via iodixanol gradient ultracentrifugation. Purified virus was buffer exchanged against PBS with 0.001% Tween and concentrated. DNase-resistant viral genomes were titered by quantitative PCR relative to standards (Aurnhammer et al., 2012) . AAV2 injections into the dorsal raphe nuclei: AAV2 viruses expressing vSWO 5-HT1A and vLWO were injected into the dorsal raphe nucleus (DRN) of wild-type (C57Bl/6J) mice. Mice 2-3 months of age were anesthetized with ketamine/xylazine (ketamine 10 mg/kg; xylazine 20 mg/kg) and placed into a stereotactic frame. Body temperature was controlled with a heating pad. A sagittal incision along the midline was made to expose the cranium, a burr hole was drilled at lambda and 0 mm lateral, and at a depth between 2,000-1,500 mm virus was injected in 100 mm steps. Virus was pressure injected by a customized glass micropipette (tip diameter $10 mm). For implantations, a customized cannula guide (Plastics One) was lowered into the brain after the virus injection and secured to the scull with the use of dental cement (Charisma). To avoid contamination of cannula guides, dummy cannulae (Plastics One) were inserted. At the end of implantation, the skin was sutured with surgical yarn. After the surgery, animals received subcutaneous injections of carprofen (2 mg/kg) for analgesia. Animals were placed individually into their home cages and allowed to recover for at least 14 days before performing electrophysiological or behavioral experiments.
In Vitro Electrophysiology and Data Analysis
For GIRK channel recordings in HEK293 cells, light-sensitive GPCRs were expressed in HEK293 cells stably expressing GIRK1/2 subunits. Cells were cultured and recorded in dark room conditions after transfection. GIRK-mediated K + -currents were measured and analyzed as described previously (Li et al., 2005) . The external solution was as follows: 20 mM NaCl, 120 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES-KOH, pH 7.3 (KOH). Patch pipettes (2-5 megaohm) were filled with internal solution: 100 mM potassium aspartate, 40 mM KCl, 5 mM Mg ATP, 10 mM HEPES-KOH, 5 mM NaCl, 2 mM EGTA, 2 mM MgCl 2 , 0.01 mM GTP, pH 7.3 (KOH). Cells were recorded in external solution containing 1 mM 9-cis-retinal (Sigma). Cells were visualized using a trans-illuminated red light (590 nm) or blue light filter (450 nm) during experimental manipulations. Whole-cell patch clamp recordings of HEK293 cells were performed with an EPC9 amplifier (HEKA). Currents were digitized at 10 kHz and filtered with the internal 10-kHz three-pole Bessel filter (filter 1) in series with a 2.9 kHz 4-pole Bessel filter (filter 2) of the EPC9 amplifier. Series resistances were partially compensated between 70% and 90%. Leak and capacitive currents were subtracted by using hyperpolarizing pulses from À60 mV to À70 mV with the p/4 method.
Brain Slice Recordings
Coronal slices including dorsal raphe (250 mm thick) were cut from brainstems of the mice 14-21 days after AAV2 injection and recordings were performed according to Oh et al. (2010) . Briefly, mice were anesthetized with isoflurane and decapitated. The brainstem was sliced in ice-cold solution containing 87 mM NaCl, 75 mM sucrose, 2.5 mM KCl, 0.5 mM CaCl 2 , 7 mM MgCl 2 , 1.25 mM NaH2 PO4, 25 mM NaHCO 3 , and 20 mM glucose bubbled with 95% O 2 and 5% CO 2 using with a vibratome (VT1000S, Leica). Slices were stored for at least 1 hr at room temperature in a recording artificial cerebrospinal fluid containing 124 mM NaCl, 3 mM KCl, 2.5 mM CaCl 2 , 1.2 mM MgSO 4 , 1.23 mM NaH 2 PO 4 , 26 mM NaHCO 3 , and 10 mM glucose bubbled with 95% O 2 and 5% CO 2 . Fluorescent mCherry or GFP-positive cells were visually identified under an upright microscope (DMLFSA, Leica) equipped with a monochromator system (Polychrome IV, TILL Photonics) flashing excitation light (light intensity, 1 mW/mm 2 ). Whole-cell recordings were made at room temperature in the dark except for using infrared light to target the cell. Slices were preincubated at least 20 min and continuously perfused with the external solution including 25 mM 9-cis-retinal, 0.025% (±)-a-tocopherol (Sigma), 0.2% essentially fatty acid-free albumin from bovine serum (Sigma), and 0.1% dimethyl sulfoxide. Patch pipettes (2-4 megaohm) were filled with an internal solution with the composition 125 mM potassium gluconate, 4 mM NaCl, 2 mM MgCl 2 10 mM HEPES, 0.2 mM EGTA, 4 mM Mg-ATP, 0.4 mM Na-GTP, and 10 mM Tris-phosphocreatine, pH 7.3 (KOH). Membrane currents and voltages were recorded with an EPC10/2 amplifier (HEKA). The signals were filtered at 3 kHz and digitized at 50 kHz. The PatchMaster software (HEKA) was used for the controls of voltage and data acquisition, and off-line analysis was made with Igor Pro 6.0 software (Wavemetrics).
In Vivo Extracellular Recordings and Optical Stimulation
For extracellular in vivo recordings, anesthetized mice were placed in a stereotactic frame. Optrodes consisted of an optical fiber with 200 mm diameter (Thorlabs, BFL37-200) fused to a customized glass-coated tungsten recording electrode (2-3 MU). Optrodes were coupled to a blue diode-pumped laser (l = 473 nm; 20 mW; CL 2000 crystal laser) for light delivery. Light intensity at the tip of the optrode was 0.5-1 mW/mm 2 . Single-and multiunit potentials were amplified and filtered (Gain 10 kHz; 300 Hz-10 kHz band-pass; A-M Systems, model 1800). After noise elimination (50/60 Hz Noise Eliminator, Quest Scientific), potentials were stored with a sampling rate of 20 kHz using a 1401 Power mk interface (CED) and analyzed offline using Spike2 software. One trial lasted 70 or 90 s, including 30 s baseline recordings, 10 or 30 s light stimulation, followed by additional 30 s baseline recordings. Five to ten trials were recorded for each cell. Data analysis was done offline by a customized MATLAB program and Igor 6.0 (Wavemetrics). Statistical significance throughout the experiments was tested with ANOVA. For immunohistology and immunohistochemistry, adult mice were deeply anesthetized before transcardial perfusion with 4% paraformaldehyde in 0.1 M PBS for 20 min. The brain was then removed and postfixed in paraformaldehyde for another 1 hr at room temperature followed by cryoprotection in 30% sucrose (w/v) overnight at 4 C. 
Open-Field Test
For the open-field test mice, 10-12 weeks of age, were injected stereotactically with vSWO 5-HT1A into the DRN and implanted as described above. Mice were individually caged and allowed to recover for at least 14 days. Animals were moved from the holding room to the behavior room at least 1 hr prior to testing. Control mice were implanted only, received a virus injection into a different brain area, or showed no expression of vSWO 5-HT1A at all. The open-field arena consisted of an acrylic chamber (30 3 30 3 30 cm, Noldus Information Technology), subdivided into 4 3 4 equal grids. The inner four squares (14.5 3 14.5 cm) were defined as the center region and the remaining squares were specified as border region. Mice were anesthetized with isoflurane to facilitate withdrawal of the dummy cannula. Animals were allowed to recover from isoflurane anesthesia for a minimum of 5 min. Optical stimulation was applied through a fiber-optic cannula (cannula: plastic one; optical commutator: Doric lenses) targeting the DRN. Fibers were attached to a patch cord (Doric lenses) coupled to a blue diode laser (CL 2000; 20 mW, crystal laser). Mice were placed into the center of the open-field and videos were analyzed using automatic tracking software (EthoVision XT 8.5; Noldus) for time spent in the center and total distance traveled. Each mouse was measured with the same protocol, comprising 3 min constant light stimulation alternating with 3 min without optical stimulation, in three subsequent trials.
Novelty-Suppressed Feeding
Mice were deprived from food 24-27 hr prior testing with water available ad libitum. Individual mice were coupled to a fiber patch cord for constant light delivery under short isoflurane anesthesia as described previously and allowed to recover from handling for 5 min. A familiar food pellet (weighing $2 g) was placed on a filter paper (60 mm in diameter) into the middle of an arena (30 3 30 3 30 cm), brightly illuminated with two 75 W incandescent bulbs. Mice were placed into the corner of the arena covered with clean wood chips and laser stimulation was applied as long as mice started to feed. The task ended when the mice first fed, defined as biting the food pellet with use of forepaws. Mice were removed from the arena, released from the fiber patch cord, and placed into their homecage to measure food consumption for an additional 5 min.
All experiments were approved by the Institutional Animal Research Facility.
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